Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 2 (2005), Issue 4 (April)

1. No evidence for production of intrathecal immunoglobulin G against Acinetobacter or Pseudomonas in multiple sclerosis.
   Eur Neurol, 53(1): 27-31. [Abstract] [Full-text]
2. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions.
   J Neurovirol, 11(1): 23-33. [Abstract] [Full-text]
3. Brain MRI in late-onset multiple sclerosis.
   Eur J Neurol, 12(4): 241-4. [Abstract] [Full-text]
4. Multi-slice echo-planar spectroscopic MR imaging provides both global and local metabolite measures in multiple sclerosis.
   Magn Reson Med, 53(4): 750-9. [Abstract] [Full-text]
5. Multiple sclerosis: novel perspectives on newly forming lesions.
   Trends Neurosci, 28(4): 173-5. [Abstract] [Full-text]
6. Blockade of Ca2+-activated K+ channels in T cells: an option for the treatment of multiple sclerosis?
   Eur J Immunol, 35(4): 1023-6. [Abstract] [Full-text]
7. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells.
   Proc Natl Acad Sci U S A, 102(14): 5150-5. [Abstract] [Full-text]
8. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
   J Neurosci Res, 80(3): 301-8. [Abstract] [Full-text]
9. Cognitive impairment in primary and secondary progressive multiple sclerosis.
   J Clin Exp Neuropsychol, 27(1): 65-77. [Abstract] [Full-text]
10. Cerebral activation patterns during working memory performance in multiple sclerosis using FMRI.
    J Clin Exp Neuropsychol, 27(1): 33-54. [Abstract] [Full-text]
11. Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral.
    Arch Neurol, 62(4): 585-90. [Abstract] [Full-text]
12. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Arch Neurol, 62(4): 578-84. [Abstract] [Full-text]
13. Early differential diagnosis of multiple sclerosis using a new oligoclonal band test.
    Arch Neurol, 62(4): 574-7. [Abstract] [Full-text]
14. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.
    Arch Neurol, 62(4): 569-73. [Abstract] [Full-text]
15. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
    Arch Neurol, 62(4): 563-8. [Abstract] [Full-text]
16. Paced visual serial addition test in multiple sclerosis.
    Clin Neurol Neurosurg, 107(3): 218-22. [Abstract] [Full-text]
17. Pilocarpine-induced sweat gland function in individuals with multiple sclerosis.
    J Appl Physiol, 98(5): 1740-4. [Abstract] [Full-text]
18. Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves.
    J Neurol Neurosurg Psychiatry, 76(5): 744-9. [Abstract] [Full-text]
19. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis.
    J Neurol Neurosurg Psychiatry, 76(5): 700-5. [Abstract] [Full-text]
20. The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis.
    J Neurol Neurosurg Psychiatry, 76(5): 656-62. [Abstract] [Full-text]
21. Mitoxantrone as rescue therapy in worsening relapsing-remitting MS patients receiving IFN-beta.
    J Neuroimmunol, 162(1): 173-83. [Abstract] [Full-text]
22. Treatment of multiple sclerosis: beyond the NICE guidelines.
    QJM, 98(5): 373-8. [Abstract] [Full-text]
23. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Immunogenetics, 57(1): 69-76. [Abstract] [Full-text]
24. Co-purification of soluble membrane cofactor protein (CD46) and human herpesvirus 6 variant A genome in serum from multiple sclerosis patients.
    Virus Res, 110(1): 57-63. [Abstract] [Full-text]
25. CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis.
    Brain, 128: 1003-15. [Abstract] [Full-text]
26. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.
    Brain, 128: 1016-25. [Abstract] [Full-text]
27. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.
    Brain, 128: 988-1002. [Abstract] [Full-text]
28. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis.
    Lancet Neurol, 4(5): 281-8. [Abstract] [Full-text]
29. Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients.
    Neuroimage, 25(4): 1272-8. [Abstract] [Full-text]
30. Hormone regulation of microglial cell activation: relevance to multiple sclerosis.
    Brain Res Brain Res Rev, 48(2): 322-7. [Abstract] [Full-text]
31. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    J Neurol Sci, 232(1): 65-9. [Abstract] [Full-text]
32. Familial recurrence rates and genetic models of multiple sclerosis.
    Am J Med Genet A, 135(1): 53-8. [Abstract] [Full-text]
33. Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis.
    Neurosci Lett, 380(1): 122-6. [Abstract] [Full-text]
34. Haplotype analysis of the preprotachykinin-1 (TAC1) gene in multiple sclerosis.
    Genes Immun, 6(3): 265-70. [Abstract] [Full-text]
35. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
    Nat Genet, 37(5): 486-94. [Abstract] [Full-text]

© 2004-2012 Multiple Sclerosis Research Today. All Rights Reserved.